Research

Energy balance

In the study, 8.7% of participants receiving GLP-1 RA had a cardiovascular event compared to 11.2% of those receiving placebo.

The data indicates a lower incidence of cardiovascular events with GLP-1 RA treatment.

StrongSupportsmedium confidence
During follow-up, 673 participants receiving GLP-1 RA treatment (8.7%) and 416 participants receiving placebo (11.2%) had a cardiovascular event.
Ana Rita Leite et al. · Diabetes Obesity and Metabolism · 2022

Why this rating

Based on a meta-analysis of placebo-controlled randomized controlled trials.

Source

Effect of glucagon‐like peptide‐1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta‐analysis of placebo‐controlled randomized trials

Ana Rita Leite et al. · Diabetes Obesity and Metabolism · 2022

DOI 10.1111/dom.14707

Meta-analysisCited 34×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →